Public Release: 

Chronic kidney disease linked to malfunctioning mitochondria

BioMed Central

Chronic kidney disease (CKD) has been linked to oxidative stress caused by dysregulation of the genes that control mitochondria. A study in the open access journal BMC Genomics has revealed alterations in respiration gene expression in the white blood cells of CKD patients.

Gianluigi Zaza and Simona Granata, from the Renal Unit of University of Bari, Italy, led a team of researchers who carried out the genomic tests. Zaza said, "Our results suggest, for the first time, that CKD patients may have an impaired mitochondrial respiratory system and this condition may be both the consequence and the cause of enhanced oxidative stress".

The researchers found 44 genes that were up-regulated in the peripheral blood mononuclear cells of CKD patients, compared to normal controls. Of these, 11 were genes were involved in the oxidative phosphorylation system. Further tests revealed that the levels reactive oxygen species (ROS) were significantly higher in the CKD group. Zaza and his colleagues suggest that these species are part of a vicious circle of respiration dysregulation that ultimately results in CKD, "Our hypothesis is that an increased production of ROS, due to the effect of pro-inflammatory mediators, may cause a profound inhibition of the oxidative phosphorylation system leading to a compensatory 'hypertrophy' of its components. In addition, a hypertrophic and impaired oxidative phosphorylation system may prime a vicious circle, causing a continuous release of ROS".

###

Notes to Editors

1. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease
Simona Granata, Gianluigi Zaza, Simona Simone, Gaetano Villani, Dominga Latorre, Paola Pontrelli, Massimo Carella, Francesco PAOLO Schena, Giuseppe Grandaliano and Giovanni Pertosa
BMC Genomics (in press)

During embargo, article available here: http://www.biomedcentral.com/imedia/5495912042639693_article.pdf?random=600839
After the embargo, article available at journal website: http://www.biomedcentral.com/bmcgenomics/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication

2. BMC Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of genome-scale analysis, functional genomics, and proteomics. BMC Genomics (ISSN 1471-2164) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, Scopus, EMBASE, Zoological Record, Thomson Reuters (ISI) and Google Scholar.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.